Published: March 2022 | Report Code: 12275 | Available Format: PDF | Pages: 233
The global interventional vascular consumables market generated $3,929.2 million in 2021, and it is expected to grow with a CAGR of 3.8% during the forecast period, to reach $5,501.7 million by 2030. The increasing number of CVD cases across the globe is fueling the demand for interventional vascular procedures. For instance, according to the WHO, around 17.9 million people die of CVDs each year, representing 32.0% of all global deaths.
Further, the demand for minimally invasive procedures is rising among older people as they are less painful, low-risk, and economical and enable a faster recovery compared to open surgeries. This further increases the demand for consumables, such as catheters, guidewires, and embolic protection systems.
Moreover, according to the WHO, between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. Moreover, according to the World Population Ageing 2020 by the United Nations, the share of the global population aged 65 years and over is expected to increase from 9.3% in 2020 to 16.0% by 2050. The report stated that there were 727 million persons aged 65 years and over in 2020 globally.
Players operating in the market are expanding their geographical presence with the objective to offer advanced cardiovascular consumables and devices. For instance,
Report Attribute | Details |
Historical Years |
2015–2021 |
Forecast Years |
2022-2030 |
Market Size in 2021 |
$3,929.2 Million (Estimated) |
Revenue Forecast in 2030 |
$5,501.7 Million |
Growth Rate |
3.8% CAGR |
Report Scope |
Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Country Breakdown; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling |
Segments Covered |
By Type; By Product Type; By Region |
Explore more about this report - Request free sample pages
The consumables used in coronary interventional procedures accounted for around 80% revenue share in 2021. The rising cases of coronary heart disease, associated with the increasing geriatric population, are leading to the surging demand for the consumables used during coronary procedures. According to the CDC, coronary heart disease is the most-common cardiac ailment in the U.S., killing 360,900 people in 2019. Moreover, the older population mostly prefers minimally invasive procedures over open surgeries, which boosts the interventional coronary consumables demand.
Catheters are expected to progress with around 4% CAGR during the forecast period. This is ascribed to the higher prices of catheters compared to other consumables, their more-frequent usage, and availability of several types of catheters in the market. Moreover, the presence of established players, who are actively engaging in product launches, is supporting the growth of the interventional vascular catheters market. For instance, in July 2021, Medtronic plc introduced a new drug-coated balloon catheter for the treatment of coronary artery disease in Europe. This drug-coated balloon is used during percutaneous coronary intervention procedures, to treat patients with narrowed or blocked coronary arteries.
Similarly, in April 2019, Guerbet, a provider of contrast agents and solutions for medical imaging, announced the European launch of SeQure and DraKon, two novel microcatheters for peripheral embolization procedures. The SeQure and DraKon microcatheters have received the CE mark for the delivery of intra-arterial therapy and embolic materials into all peripheral vessels.
North America held the largest share, of 35.2%, in the interventional vascular consumables market in 2021. The dominance of the continent on the market is mainly attributed to the rising healthcare expenditure, increasing number of cases of chronic diseases, and growing geriatric population.
According to a report published by the Rural Health Information Hub, in the U.S., 46 million people were aged 65 and above in 2020, and this number is set to increase to almost 90 million by 2050. The booming geriatric population leads to the rising prevalence of chronic diseases, thus resulting in a high demand for interventional vascular consumables in the region. Interventional procedures are preferred by older patients as these procedures have a lower risk of complications and are affordable. Moreover, they are preferred as with age, patients’ ability to heal the scars of the surgery may diminish.
Moreover, the rising healthcare expenditure in the North American region is playing a key role in this regard, by making healthcare accessible to the masses. According to the World Bank, the healthcare expenditure of the North American region was 12.3% of its GDP in 2000, and it increased to 16.4% of the GDP in 2018.
Along with the above-mentioned factors, the North American interventional vascular consumables market is benefitted by the strong supply chain of such products due to the presence of numerous well-established interventional vascular consumable manufacturers. Key players, such as Boston Scientific Corporation, Abbott Laboratories, Cook Group Inc., Becton, Dickinson and Company, and Merit Medical Systems Inc., have their headquarters in the U.S., and they use direct and indirect channels to distribute the consumables to hospitals and clinics for interventional vascular procedures.
Key players in the market are taking concrete measures to increase their market share, strengthen their product portfolio, and improve their value proposition. For instance,
Moreover, the interventional vascular consumables market is being shaped by new medical device manufacturing and marketing regulations, due to which older devices will be gradually replaced. Therefore, the big players in the market, such as Cardinal Health Inc., Becton, Dickinson and Company, and B. Braun Melsungen AG, have started launching products that comply with the new standards. For instance:
The global interventional vascular consumables market report offers comprehensive market segmentation analysis along with market estimation for the period 2015–2030.
Based on Type
Based on Product Type
Geographical Analysis
In 2021, the estimated revenue generated by the market for interventional vascular consumables stood at $3,929.2 million.
Based on product type, the interventional vascular consumables market generates the highest revenue from the sale of catheters.
North America is the largest regional market for interventional vascular consumables.
The geriatric population acts as a key driver for the interventional vascular consumables industry as it prefers minimally invasive interventional procedures.
Players in the market for interventional vascular consumables are launching new products and entering into mergers and acquisitions to get ahead.
Get a bespoke market intelligence solution
Want a report tailored exactly to your business strategy?
Request CustomizationWant an insight-rich discussion with the report author?
Speak to AnalystOur dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws